TalkMed's Q4 net profit dips 19.3% y-o-y on fewer patient visits

Singapore

CATALIST-listed healthcare provider TalkMed Group - whose chief executive officer (CEO) and main revenue contributor was suspended by the Singapore Medical Council (SMC) last year - saw its fourth-quarter net profit fall 19.3 per cent to S$8.24 million from S$10.22 million a year ago.

This translated to an earnings per share of 0.63 Singapore cent for the quarter, from 0.78 Singapore cent in the year-ago period.

The group has recommended a one-tier tax exempt dividend of 1.37 Singapore cents per share, down from 2.28 Singapore cents per share in the preceding year. If approved by the company's shareholders at an annual general meeting to be held on A…